Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Pinterest Inc (PINS) Price & Performance

Enveric Biosciences IncTrade
Pinterest IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Pinterest Inc — how do they compare? Enveric Biosciences Inc trades at $1.49 (market cap $5.32M), while Pinterest Inc trades at $23.61 (market cap $13.26B). The key difference: Pinterest Inc is far larger — about 2492.5× Enveric Biosciences Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.

ENVBPINS
Market Cap
$5.32M$13.26B
Sector
HealthMedia
52-Week High
$17.40$39.17
52-Week Low
$1.28$15.42
Enterprise Value
$408.82K$13.17B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.

Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.

Pinterest Inc

Pinterest (PINS) trades at $22.605, showing minimal daily movement. The stock exhibits a bullish technical setup with strong analyst support (54% buy ratings) and a consensus price target of $27.72, suggesting 23% upside. Fundamentally, the company demonstrates robust revenue growth to $4.22B in 2025 and improving profitability with a 7.64% net margin, though valuation metrics remain elevated with a P/E of 49.33. Recent developments include AI shopping initiatives and strong user growth to 631M MAUs in Q1 2026.

The outlook for PINS is cautiously optimistic with clear catalysts from AI-driven monetization and e-commerce integration, but risks include high valuation multiples and competitive pressures in social commerce. Earnings momentum is mixed with a recent beat in Q1 2026 but a miss in Q3 2025. The stock's investment case hinges on sustained user growth translating to higher ARPU and margin expansion.

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Pinterest Inc

Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.

Read more on PINS